Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
June-2016 Volume 35 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2016 Volume 35 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins

  • Authors:
    • Huaiping Shi
    • Tianying Zhang
    • Yongqing Yi
    • Yue Ma
  • View Affiliations / Copyright

    Affiliations: College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, P.R. China
  • Pages: 3593-3599
    |
    Published online on: March 21, 2016
       https://doi.org/10.3892/or.2016.4696
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Although previous studies have shown that Ras-ERK signaling in mitosis is closed due to the inhibition of signal transduction, the events involved in the molecular mechanisms are still unclear. In the present study, we investigated the Ras-ERK signaling pathway in mitotic COS7 cells. The results demonstrated that treatment with epidermal growth factor (EGF) failed to increase the endocytosis of EGF-EGFR (EGF receptor) complexes in mitotic COS7 cells, although a large amount of endosomes were found in asynchronous COS7 cells. Clathrin expression levels in mitotic COS7 cells were inhibited whereas caveolin expression levels in mitotic COS7 cells were almost unaffected. Y1068 and Y1086 residues of EGFR in the mitotic COS7 cells were activated. However, Grb2 and Shc in the mitotic COS7 cells did not bind to activated EGFR. Ras activity was inhibited in the mitotic COS7 cells whereas its downstream protein, Raf, was obviously phosphorylated by EGF in mitosis. Treatment with phorbol 12-myristate 13-acetate (PMA) also increased the phosphorylation levels of Raf in the mitotic COS7 cells. Nevertheless, Raf phosphorylation in mitosis was significantly inhibited by AG1478. Lastly, activation of EGF-mediated MEK and ERK in the mitotic COS7 cells was obviously inhibited. In summary, our results suggest that the Ras-ERK pathway is inhibited in mitotic COS7 cells which may be the dual result of the difficulty in the transduction of EGF signaling by EGFR or Raf to downstream proteins.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Cha DS, Datla US, Hollis SE, Kimble J and Lee MH: The Ras-ERK MAPK regulatory network controls dedifferen-tiation in Caenorhabditis elegans germline. Biochim Biophys Acta. 1823:1847–1855. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Choi C and Helfman DM: The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2. Oncogene. 33:3668–3676. 2014. View Article : Google Scholar

3 

Nishida Y: Function of Raf/MAP kinase cascade in the regulation of cellular proliferation and differentiation. Tanpakushitsu Kakusan Koso. 41(Suppl 12): S1673–S1679. 1996.

4 

Yoon S and Seger R: The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors. 24:21–44. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Batzer AG, Rotin D, Ureña JM, Skolnik EY and Schlessinger J: Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol. 14:5192–5201. 1994. View Article : Google Scholar : PubMed/NCBI

6 

Sasaoka T, Langlois WJ, Leitner JW, Draznin B and Olefsky JM: The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. J Biol Chem. 269:32621–32625. 1994.PubMed/NCBI

7 

Kolch W: Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 351:289–305. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Higashi N, Kunimoto H, Kaneko S, Sasaki T, Ishii M, Kojima H and Nakajima K: Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation. Genes Cells. 9:233–242. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Manimala NJ, Frost CD, Lane ML, Higuera M, Beg R and Vesely DL: Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells. Eur J Clin Invest. 43:1156–1162. 2013.PubMed/NCBI

11 

Lavoie JN, L'Allemain G, Brunet A, Müller R and Pouysségur J: Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 271:20608–20616. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Weber JD, Raben DM, Phillips PJ and Baldassare JJ: Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J. 326:61–68. 1997. View Article : Google Scholar : PubMed/NCBI

13 

Berlin RD, Oliver JM and Walter RJ: Surface functions during Mitosis I: Phagocytosis, pinocytosis and mobility of surface-bound Con A. Cell. 15:327–341. 1978. View Article : Google Scholar : PubMed/NCBI

14 

Berlin RD and Oliver JM: Surface functions during mitosis. II. Quantitation of pinocytosis and kinetic characterization of the mitotic cycle with a new fluorescence technique. J Cell Biol. 85:660–671. 1980. View Article : Google Scholar : PubMed/NCBI

15 

Kreiner T and Moore HP: Membrane traffic between secretory compartments is differentially affected during mitosis. Cell Regul. 1:415–424. 1990.PubMed/NCBI

16 

Sager PR, Brown PA and Berlin RD: Analysis of transferrin recycling in mitotic and interphase HeLa cells by quantitative fluorescence microscopy. Cell. 39:275–282. 1984. View Article : Google Scholar : PubMed/NCBI

17 

Warren G, Featherstone C, Griffiths G and Burke B: Newly synthesized G protein of vesicular stomatitis virus is not transported to the cell surface during mitosis. J Cell Biol. 97:1623–1628. 1983. View Article : Google Scholar : PubMed/NCBI

18 

Hayne C, Xiang X and Luo Z: MEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis. Biochem Biophys Res Commun. 321:675–680. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Margadant C, Cremers L, Sonnenberg A and Boonstra J: MAPK uncouples cell cycle progression from cell spreading and cyto-skeletal organization in cycling cells. Cell Mol Life Sci. 70:293–307. 2013. View Article : Google Scholar :

20 

Kiyokawa N, Lee EK, Karunagaran D, Lin SY and Hung MC: Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem. 272:18656–18665. 1997. View Article : Google Scholar : PubMed/NCBI

21 

Newberry EP and Pike LJ: Cell-cycle-dependent modulation of EGF-receptor-mediated signaling. Biochem Biophys Res Commun. 208:253–259. 1995. View Article : Google Scholar : PubMed/NCBI

22 

Klein S, Kaszkin M, Barth H and Kinzel V: Signal transduction through epidermal growth factor receptor is altered in HeLa monolayer cells during mitosis. Biochem J. 322:937–946. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Laird AD, Taylor SJ, Oberst M and Shalloway D: Raf-1 is activated during mitosis. J Biol Chem. 270:26742–26745. 1995. View Article : Google Scholar : PubMed/NCBI

24 

Herrmann C, Martin GA and Wittinghofer A: Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem. 270:2901–2905. 1995. View Article : Google Scholar : PubMed/NCBI

25 

Cochet C, Kashles O, Chambaz EM, Borrello I, King CR and Schlessinger J: Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J Biol Chem. 263:3290–3295. 1988.PubMed/NCBI

26 

Gamett DC, Pearson G, Cerione RA and Friedberg I: Secondary dimerization between members of the epidermal growth factor receptor family. J Biol Chem. 272:12052–12056. 1997. View Article : Google Scholar : PubMed/NCBI

27 

Hyde R, Corkins ME, Somers GA and Hart AC: PKC-1 acts with the ERK MAPK signaling pathway to regulate Caenorhabditis elegans mechanosensory response. Genes Brain Behav. 10:286–298. 2011. View Article : Google Scholar

28 

Couet J, Sargiacomo M and Lisanti MP: Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 272:30429–30438. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Mineo C, Gill GN and Anderson RG: Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem. 274:30636–30643. 1999. View Article : Google Scholar : PubMed/NCBI

30 

Smart EJ, Ying YS, Mineo C and Anderson RG: A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA. 92:10104–10108. 1995. View Article : Google Scholar : PubMed/NCBI

31 

Yamabhai M and Anderson RG: Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J Biol Chem. 277:24843–24846. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 56:881–914. 1987. View Article : Google Scholar : PubMed/NCBI

33 

Fielding AB, Willox AK, Okeke E and Royle SJ: Clathrin-mediated endocytosis is inhibited during mitosis. Proc Natl Acad Sci USA. 109:6572–6577. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Aguilar RC and Wendland B: Endocytosis of membrane receptors: Two pathways are better than one. Proc Natl Acad Sci USA. 102:2679–2680. 2005. View Article : Google Scholar : PubMed/NCBI

35 

Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW and Burgess AW: Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp Cell Res. 284:31–53. 2003. View Article : Google Scholar : PubMed/NCBI

36 

Pawson T: Specificity in signal transduction: From phosphot-yrosine-SH2 domain interactions to complex cellular systems. Cell. 116:191–203. 2004. View Article : Google Scholar : PubMed/NCBI

37 

Morrison DK and Cutler RE Jr: The complexity of Raf-1 regulation. Curr Opin Cell Biol. 9:174–179. 1997. View Article : Google Scholar : PubMed/NCBI

38 

Vojtek AB, Hollenberg SM and Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 74:205–214. 1993. View Article : Google Scholar : PubMed/NCBI

39 

Dangi S and Shapiro P: Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosis. J Biol Chem. 280:24524–24531. 2005. View Article : Google Scholar : PubMed/NCBI

40 

Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM and Sturgill TW: Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science. 257:1404–1407. 1992. View Article : Google Scholar : PubMed/NCBI

41 

Howe LR, Leevers SJ, Gómez N, Nakielny S, Cohen P and Marshall CJ: Activation of the MAP kinase pathway by the protein kinase raf. Cell. 71:335–342. 1992. View Article : Google Scholar : PubMed/NCBI

42 

Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR and Avruch J: Raf-1 activates MAP kinase-kinase. Nature. 358:417–421. 1992. View Article : Google Scholar : PubMed/NCBI

43 

Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ and Johnson GL: A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 260:315–319. 1993. View Article : Google Scholar : PubMed/NCBI

44 

Moodie SA, Willumsen BM, Weber MJ and Wolfman A: Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase kinase. Science. 260:1658–1661. 1993. View Article : Google Scholar : PubMed/NCBI

45 

Laird AD, Morrison DK and Shalloway D: Characterization of Raf-1 activation in mitosis. J Biol Chem. 274:4430–4439. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shi H, Zhang T, Yi Y and Ma Y: Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins. Oncol Rep 35: 3593-3599, 2016.
APA
Shi, H., Zhang, T., Yi, Y., & Ma, Y. (2016). Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins. Oncology Reports, 35, 3593-3599. https://doi.org/10.3892/or.2016.4696
MLA
Shi, H., Zhang, T., Yi, Y., Ma, Y."Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins". Oncology Reports 35.6 (2016): 3593-3599.
Chicago
Shi, H., Zhang, T., Yi, Y., Ma, Y."Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins". Oncology Reports 35, no. 6 (2016): 3593-3599. https://doi.org/10.3892/or.2016.4696
Copy and paste a formatted citation
x
Spandidos Publications style
Shi H, Zhang T, Yi Y and Ma Y: Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins. Oncol Rep 35: 3593-3599, 2016.
APA
Shi, H., Zhang, T., Yi, Y., & Ma, Y. (2016). Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins. Oncology Reports, 35, 3593-3599. https://doi.org/10.3892/or.2016.4696
MLA
Shi, H., Zhang, T., Yi, Y., Ma, Y."Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins". Oncology Reports 35.6 (2016): 3593-3599.
Chicago
Shi, H., Zhang, T., Yi, Y., Ma, Y."Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins". Oncology Reports 35, no. 6 (2016): 3593-3599. https://doi.org/10.3892/or.2016.4696
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team